PMC:7755033 / 6367-6611 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"180","span":{"begin":53,"end":58},"obj":"Species"},{"id":"181","span":{"begin":70,"end":74},"obj":"Species"},{"id":"189","span":{"begin":124,"end":134},"obj":"Chemical"},{"id":"190","span":{"begin":144,"end":154},"obj":"Chemical"},{"id":"191","span":{"begin":156,"end":176},"obj":"Chemical"},{"id":"192","span":{"begin":184,"end":194},"obj":"Chemical"},{"id":"193","span":{"begin":196,"end":203},"obj":"Chemical"},{"id":"194","span":{"begin":209,"end":219},"obj":"Chemical"},{"id":"195","span":{"begin":221,"end":224},"obj":"Chemical"}],"attributes":[{"id":"A180","pred":"tao:has_database_id","subj":"180","obj":"Tax:9606"},{"id":"A181","pred":"tao:has_database_id","subj":"181","obj":"Tax:11118"},{"id":"A189","pred":"tao:has_database_id","subj":"189","obj":"MESH:D009705"},{"id":"A190","pred":"tao:has_database_id","subj":"190","obj":"MESH:C000606551"},{"id":"A191","pred":"tao:has_database_id","subj":"191","obj":"MESH:D000068698"},{"id":"A192","pred":"tao:has_database_id","subj":"192","obj":"MESH:C086979"},{"id":"A193","pred":"tao:has_database_id","subj":"193","obj":"MESH:C086979"},{"id":"A194","pred":"tao:has_database_id","subj":"194","obj":"MESH:D019259"},{"id":"A195","pred":"tao:has_database_id","subj":"195","obj":"MESH:D019259"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Several antiviral therapies have been identified for human pathogenic CoVs including synthetic inhibitors of neuraminidase, nucleoside analogs, remdesivir, tenofovir disoproxil (TDF), umifenovir (arbidol) and lamivudine (3TC) (Li et al., 2005)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T46","span":{"begin":0,"end":244},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Several antiviral therapies have been identified for human pathogenic CoVs including synthetic inhibitors of neuraminidase, nucleoside analogs, remdesivir, tenofovir disoproxil (TDF), umifenovir (arbidol) and lamivudine (3TC) (Li et al., 2005)."}